Literature DB >> 31943354

Psychosocial aspects of diabetes technology.

T Kubiak1, L Priesterroth1, K D Barnard-Kelly2,3.   

Abstract

AIM: To identify key psychosocial research in the domain of diabetes technology.
RESULTS: Four trajectories of psychosocial diabetes technology research are identified that characterize research over the past 25 years. Key evidence is reviewed on psychosocial outcomes of technology use as well as psychosocial barriers and facilitating conditions of diabetes technology uptake. Psychosocial interventions that address modifiable barriers and psychosocial factors have proven to be effective in improving glycaemic and self-reported outcomes in diabetes technology users.
CONCLUSIONS: Psychosocial diabetes technology research is essential for designing interventions and education programmes targeting the person with diabetes to facilitate optimized outcomes associated with technology uptake. Psychosocial aspects of diabetes technology use and related research will be even more important in the future given the advent of systems for automated insulin delivery and the increasingly widespread digitalization of diabetes care.
© 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31943354     DOI: 10.1111/dme.14234

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial.

Authors:  Ingvild Hernar; Marit Graue; David A Richards; Ragnhild B Strandberg; Roy Miodini Nilsen; Magne Rekdal; Karianne Fjeld Løvaas; Tone V Madsen; Grethe S Tell; Anne Haugstvedt
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

2.  Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes.

Authors:  Marisa E Hilliard; Persis V Commissariat; Lauren Kanapka; Lori M Laffel; Wendy Levy; Kara Harrington; Barbara J Anderson; Kellee M Miller; Linda A DiMeglio
Journal:  Pediatr Diabetes       Date:  2022-05-19       Impact factor: 3.409

3.  COVID-19 and diabetes.

Authors:  R C W Ma; R I G Holt
Journal:  Diabet Med       Date:  2020-04-03       Impact factor: 4.213

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.